Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1

NCT06131983 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Facio-Scapulo-Humeral Dystrophy

Interventions

DRUG: ARO-DUX4 for Injection
DRUG: Placebo

Sponsor

Arrowhead Pharmaceuticals